Balyasny Asset Management LLC X Biotech Inc. Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$4.03 - $8.13 $88,115 - $177,762	21,865 New	21,865 $177,000
Q2 2020 Aug 14, 2020	SELL	$10.39 - $16.07 $523,936 - $810,361	-50,427 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$8.89 - $24.94 $448,296 - $1.26 Million	50,427 New	50,427 $536,000
Q3 2019 Nov 14, 2019	SELL	$6.86 - $10.46 $1.46 Million - $2.23 Million	-213,100 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$6.99 - $11.27 $411,340 - $663,205	-58,847 Reduced 21.64%	213,100 $1.62 Million
Q1 2019 May 15, 2019	BUY	$5.05 - $11.62 $1.37 Million - $3.16 Million	271,947 New	271,947 $3 Million

4.67M

5.8K

4.6K

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $219M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.